Energy balance
Endoscopic interventions such as Endoscopic Sleeve Gastroplasty (ESG) and Transoral Outlet Reduction (TORe) are effective minimally invasive treatments for managing post-bariatric recurrent weight gain (RWG).
If you are gaining weight back after bariatric surgery, ask your doctor about endoscopic procedures like ESG or TORe. These are minimally invasive options that can help with weight loss without the risks of major surgery. They work by mechanically restricting your stomach or outlet size. While they are not as effective as GLP-1 drugs in some cases, they are a valuable tool for managing RWG.
Endoscopic sleeve gastroplasty (ESG) involved creating a two-row plication... resulting in 9-kilogram decrease... Transoral Outlet Reduction (TORe)... achieved a 3.5% total weight loss (TWL), a statistically significant improvement over the 0.4% TWL observed in the control group that received a sham procedure (p = 0.02) after 1 year (69).
Source
Prognosticating post-bariatric surgery outcomes and management of postoperative recurrent weight gain and diabetes recurrence
Xiao He et al. · Frontiers in Nutrition · 2024
DOI 10.3389/fnut.2024.1510403
More from this paper
- Post-bariatric recurrent weight gain (RWG) can be effectively managed with FDA-approved anti-obesity medications (AOMs) such as GLP-1 receptor agonists (liraglutide, semaglutide), phentermine/topiramate, naltrexone/bupropion, and orlistat, which reduce weight regain or aid weight loss.Good
- Post-bariatric recurrent weight gain (RWG) can be managed with other FDA-approved anti-obesity medications including phentermine/topiramate, naltrexone/bupropion, and orlistat, which reduce weight regain or aid weight loss.Good
- Conversional surgeries (e.g., RYGB, SADI-S, DS) are effective for managing post-bariatric recurrent weight gain (RWG) and diabetes recurrence, but carry higher risks of complications compared to primary surgery.Good
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →